docetaxel and cisplatin
Sponsors
Swiss Cancer Institute, Sanofi, University of Wisconsin, Madison, University of Chicago, Gyeongsang National University Hospital
Conditions
Esophageal CancerEsophageal Squamous Cell CarcinomaHead and Neck NeoplasmsHead and Neck Squamous Cell Carcinoma HNSCCHypopharyngeal CancerInoperable Gastric CancerLiver Injury, Drug-InducedNasopharyngeal Squamous Cell Carcinoma
Phase 2
Docetaxel, Cisplatin, and Radiation Therapy in Treating Patients With Locally Advanced Esophageal Cancer That Cannot Be Removed By Surgery
CompletedNCT00238407
Start: 2004-03-31End: 2010-08-31Updated: 2012-06-05
Safety Study of Docetaxel/Cisplatin Induction Therapy Followed by Concurrent Chemoradiotherapy or Concurrent Chemoradiotherapy Followed by Consolidation Docetaxel/Cisplatin in NSCLC Patients
TerminatedNCT00271323
Start: 2005-05-31End: 2007-02-28Updated: 2009-12-23
Study of Combination Docetaxel and Radiotherapy With or Without Cisplatin to Treat Local Advanced Head and Neck Cancer
CompletedNCT00521521
Start: 2001-07-31Updated: 2009-12-07
Adjuvant Cisplatin and Docetaxel in Non Small Cell Lung Cancer
CompletedNCT00582634
Start: 2004-09-30End: 2007-12-31Updated: 2019-11-19
Efficacy and Safety of Subsequent Cisplatin and Docetaxel in Ovarian Cancer
CompletedNCT00772863
Start: 2003-09-30Updated: 2009-10-29
The Synergistic Metastases Annihilation With Radiotherapy and Docetaxel (Taxotere) [SMART] Trial for Non-Small Cell Lung Cancer (NSCLC)
TerminatedNCT00887315
Start: 2009-04-30End: 2011-06-30Updated: 2013-12-06
Biweekly Schedule of Docetaxel and Cisplatin in High Risk Patients With Unresectable Non-small Cell Lung Cancer (NSCLC)
CompletedNCT00995761
Start: 2009-10-31End: 2012-08-31Updated: 2014-03-03
Safety and Efficacy Study of Nimotuzumab Plus Neoadjuvant and Concurrent Chemoradiotherapy to Treat Oropharynx and Hypopharynx Cancer
NCT01516996
Start: 2012-03-31End: 2018-03-31Target: 80Updated: 2012-03-20
GP VS TP in the Treatment of Advanced Nasopharyngeal Carcinoma in Northwest China
CompletedNCT01596868
Start: 2012-05-31End: 2013-10-31Target: 60Updated: 2013-10-30
Nimotuzumab Combined With Chemoradiotherapy for Unresectable Locally Advanced Squamous Cell Lung Cancer
CompletedNCT02577341
Start: 2015-08-31End: 2020-10-31Updated: 2021-02-11
Phase 3
FOLFIRI Versus Docetaxel and Cisplatin as a Second-line Chemotherapy After Failure of First-line Chemotherapy in Advanced Gastric Cancer
CompletedNCT03067792
Start: 2014-12-31End: 2016-10-17Updated: 2017-03-01
Toripalimab ± Chemo as Neoadjuvant Therapy in LA-HNSCC: A Phase III Trial
Not yet recruitingNCT07371897
Start: 2026-06-30End: 2026-09-30Target: 154Updated: 2026-01-28
Phase 4
Efficacy of Chemoradiotherapy After Neoadjuvant Cisplatin and Docetaxel in the Nasopharynx Carcinoma
CompletedNCT00772681
Start: 2004-10-31End: 2008-03-31Updated: 2009-12-07
Clarify of Predictive Risk Factors of Chemotherapy-induced Liver Injury
NCT03069820
Start: 2017-02-10End: 2018-01-01Target: 120Updated: 2017-03-03